About: toxic diffuse goiter

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: toxic diffuse goiter Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

autoimmune disease of endocrine system that involves production of excessive amount of thyroid hormones, located in thyroid gland

Attributes	Values
rdf:type	Item
owl:sameAs	toxic diffuse goiter
description	autoimmune disease of endocrine system that involves production of excessive amount of thyroid hormones, located in thyroid gland (en)
exact match	wds:Q50357588-479DA2A9-6911-4948-BBAA-6A51BBD54307 wds:Q50357588-818FF05B-9615-4758-B919-D3EB22437ECC
exact match	http://purl.obolibrary.org/obo/DOID_12361 http://identifiers.org/doid/DOID:12361
Experimental Factor Ontology ID	wds:Q50357588-F54B5743-29F2-497A-AF83-E00F2D94394C
health specialty	wds:Q50357588-0CEBF7E2-DF16-4017-9934-87191F7EB0C0 wds:Q50357588-3B548613-A0B9-480A-B663-1EC9210BAB36 wds:Q50357588-6158B577-5458-4975-AB60-15C87B19A3E4
Disease Ontology ID	wds:Q50357588-0BD8AD44-6932-4E45-A5F4-157189CFEEF0
Disease Ontology ID	http://purl.obolibrary.org/obo/DOID_DOID:12361
Experimental Factor Ontology ID	0004237
health specialty	ophthalmology endocrinology immunology
Disease Ontology ID	DOID:12361
rdfs:label	Graves' disease (en) maladie de Graves (fr)
skos:prefLabel	Graves' disease (en) maladie de Graves (fr)
name	Graves' disease (en) maladie de Graves (fr)
instance of	wds:Q50357588-85C9170B-13F6-430F-8D50-24138A2A1557
instance of	class of disease
said to be the same as	wds:Q50357588-ec21ff22-4d7f-61c1-76c6-0d75ff4c6ffd
said to be the same as	toxic diffuse goiter
subclass of	wds:Q50357588-81292E1A-3153-463D-BF08-CE062D39A577
subclass of	autoimmune disease of endocrine system
KEGG ID	wds:Q50357588-EA6209A5-88CF-4A58-9DED-A9D806E05AFF
KEGG ID	http://www.kegg.jp/entry/H00082
KEGG ID	H00082
genetic association	wds:Q50357588-44745500-85B3-4085-8EDB-7C9EB786333C wds:Q50357588-4A58E1AD-04A9-4E9A-8BB5-DBE9B1271632 wds:Q50357588-8F714C36-8617-40DE-8487-8CF2B666AB5D wds:Q50357588-A8A8C85E-2847-42F8-870C-BD6232A93CDB
ICD-10-CM	wds:Q50357588-5CB16F05-7AFB-48C0-ABBF-35DC7584CAB9
PatientsLikeMe condition ID	wds:Q50357588-f877f010-4d0d-8e68-65c8-df5f43288776
genetic association	FCRL3 ABO SLAMF6 TSHR
ICD-10-CM	E05.0
PatientsLikeMe condition ID	graves-disease
skos:altLabel	Basedow's disease (en) Grave's disease (en) Graves disease (en) exophthalmic goiter (en)
NCI Thesaurus ID	wds:Q50357588-0EEB1FA1-C9E2-40B9-87CE-A6D0A362896F
UMLS CUI	wds:Q50357588-94D14544-B681-43DD-B14B-76D487200174
subreddit	wds:Q50357588-1378a978-45fe-a516-c5b5-b04f010db272
MeSH descriptor ID	wds:Q50357588-CE6DF46C-39D6-4FB5-8E9C-424A18F5FB0E
on focus list of Wikimedia project	wds:Q50357588-599931D6-6308-4F4F-B6E9-F244AEB39694
MeSH tree code	wds:Q50357588-0740B7AF-AEA9-46BA-B10D-379F7CAB7C34 wds:Q50357588-25DBC4AF-B6A0-4DA4-BE5B-6B562161E5E3 wds:Q50357588-658BD71A-BF43-4B4C-8DED-B103D29F980A wds:Q50357588-CED3965C-7ED2-42BC-8D4B-80D16A6EE037
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/D006111
MeSH tree code	http://id.nlm.nih.gov/mesh/C11.675.349.500 http://id.nlm.nih.gov/mesh/C19.874.283.605 http://id.nlm.nih.gov/mesh/C19.874.397.370 http://id.nlm.nih.gov/mesh/C20.111.555
NCI Thesaurus ID	C3071
UMLS CUI	C0018213
subreddit	gravesdisease
MeSH descriptor ID	D006111
on focus list of Wikimedia project	WikiProject Medicine
MeSH tree code	C11.675.349.500 C19.874.283.605 C19.874.397.370 C20.111.555
is about of	toxic diffuse goiter https://www.wikidata.org/wiki/Special:EntityData/Q50357588
is main subject of	Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy Short- and long-term results of total vs subtotal thyroidectomies in the surgical treatment of Graves' disease Differences and Similarities in the Diagnosis and Treatment of Graves' Disease in Europe, Japan, and The United States Use of cold iodine in patients with Graves' disease: observations from a clinical practice Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Surgical treatment of Graves' disease: evidence-based approach Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves' disease in the United States Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy? Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre? Surgical management of Graves' disease -10-year prospective trial at a single institution. Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients. Scottish Automated Follow-Up Register Group Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment The efficacy of thyroidectomy for Graves' disease: A meta-analysis Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study Change in the intrathyroidal kinetics of radioiodine under continued and discontinued antithyroid medication in Graves' disease Lithium as an adjunct to radioiodine therapy in Graves' disease for prolonging the intrathyroidal effective half-life of radioiodine. Useful or not? Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study Surgery versus radioiodine therapy as definitive management for graves' disease: the role of patient preference A prospective randomized comparison of bilateral subtotal thyroidectomy versus unilateral total and contralateral subtotal thyroidectomy for graves' disease Near total thyroidectomy is an optimal treatment for graves' disease Comparison of two fixed activities of radioiodine therapy (370 vs. 555 MBq) in patients with Graves' disease Extensive thyroidectomy in Graves' disease Striving for euthyroidism in radioiodine therapy of Graves' disease: a 12-year prospective, randomized, open-label blinded end point study The surgical treatment of Graves' disease in children and adolescents

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software